Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
TOMI Environmental Solutions Inc(TOMZ)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for TOMZ
10/23/2026: TOMZ (1-star) is currently NOT-A-BUY. Pass it for now.
TOMI Environmental Solutions is a small-cap company providing specialized decontamination technology via its proprietary SteraMist ionized Hydrogen Peroxide system. Its core strengths lie in its patented technology and EPA-registered efficacy, which help it compete in hospital and life science markets. While the company has seen success during health-conscious periods, it remains a volatile investment facing intense competition from large medical incumbents like STERIS. Primary risks involve high operational costs and execution in a capital-intensive market. The stock may suit growth-oriented investors with a high risk tolerance who are looking for exposure to the infection control sector, provided they monitor ongoing revenue growth and margin improvements closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers exposure to high-growth infection control technology but faces significant execution risks in scaling operations. |
| Momentum investor | Strong fit while signal remains positive | The stock can exhibit high beta and sensitivity to news cycles regarding public health concerns. |
| Value investor | Weak fit | The company's earnings volatility and lack of a stable track record make it less suitable for traditional value strategies. |
| Dividend investor | Weak fit | TOMI does not pay a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | High volatility and operational risks characterize this stock as a high-risk investment. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock's low market cap and sector sensitivity lead to significant daily price swings. |
| Valuation risk | Medium / high | Valuations are often speculative, relying on future growth projections that may be difficult to realize. |
| Competition risk (large medical device incumbents) | High | Competing with firms like STERIS and Ecolab limits pricing power and market access. |
| Business quality | Medium | While the technology is innovative, achieving sustained, high-margin profitability remains an ongoing challenge. |
| Dividend income | Low / none | There is no income generation from this equity. |
| Execution risk | Medium / high | Scaling technology to new global markets requires consistent operational success and capital. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -29.01% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.30M USD | Price to earnings Ratio - | 1Y Target Price 7 |
Price to earnings Ratio - | 1Y Target Price 7 | ||
Volume (30-day avg) 117.6K shares | Beta 1.95 | 52 Weeks Range 1.21 - 3.33 | Updated Date 10/24/2026 |
52 Weeks Range 1.21 - 3.33 | Updated Date 10/24/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.5 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Equipment Sales | Sale of SteraMist iHP units to hospitals, labs, and commercial clients. | Hardware sales drive initial adoption and build the installed base. |
| Consumables & Services | Proprietary hydrogen peroxide solutions and professional disinfection services. | This is the company's recurring revenue engine, essential for long-term growth. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 13.59 | Enterprise Value 16.10M | Price to Sales(TTM) 2.06 |
Enterprise Value 16.10M | Price to Sales(TTM) 2.06 | ||
Enterprise Value to Revenue 2.36 | Enterprise Value to EBITDA -2.69 | Shares Outstanding 9.79M | Shares Floating 5.77M |
Shares Outstanding 9.79M | Shares Floating 5.77M | ||
Percent Insiders 25 | Percent Institutions 3.7 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.